DBCO vs BCN for Copper-Free Click Chemistry: Reactivity, Size, and Workflow Selection

DBCO and BCN both exploit ring strain to accelerate azide–alkyne cycloaddition without copper, but their molecular architectures create different practical trade-offs.

DBCO, commonly used as shorthand for dibenzocyclooctyne-based reagents, contains fused aromatic rings that increase strain and provide a recognizable UV chromophore. Commercial DBCO reagents are available with many linkers, activated esters, fluorophores, PEG spacers, and payloads. The aromatic framework, however, can increase hydrophobicity and nonspecific interactions in some biomolecule systems.

BCN, bicyclo[6.1.0]nonyne, is a smaller aliphatic strained alkyne. Its compact size can reduce steric burden when the clickable handle must sit close to a protein surface, peptide backbone, oligonucleotide, or densely functionalized material. BCN derivatives also vary in linker and substitution, so "BCN is always more soluble" is not a reliable universal rule.

The practical comparison should therefore focus on the complete reagent—not only the strained ring. A PEG-linked DBCO may behave more hydrophilically than a BCN attached to a lipophilic payload. Likewise, a sterically exposed DBCO can outperform a nominally smaller BCN that is buried by an unfavorable attachment geometry.

The table below frames the selection around variables that commonly affect conversion, purification, and final conjugate quality.

Reported second-order SPAAC rate constants are useful for orientation, but they do not fully predict conversion on a protein, antibody, oligonucleotide, or surface.

Intrinsic cycloaddition rate is influenced by ring strain and electronics, yet practical conversion also depends on local accessibility, effective concentration, solvent composition, and whether the reactive group is partially buried. DBCO-family reagents are widely used because they provide a strong combination of reactivity and reagent accessibility. BCN provides a different balance and can perform especially well when its smaller footprint improves access to the azide.

The azide partner is not passive. Alkyl azides, aryl azides, electron-deficient azides, and sterically constrained azides can differ in reaction behavior. When comparing DBCO and BCN for a specific conjugation, the relevant experiment is the actual reagent pair in the intended buffer—not a cross-study comparison using different azides.

Reaction rate also interacts with purification. A modestly faster reagent may not improve overall process yield if it causes more nonspecific adsorption, aggregation, or difficult separation. The useful endpoint is purified conjugate recovery at the desired labeling distribution.

Physical properties are often the deciding factor when SPAAC is applied to large biomolecules or high labeling densities.

DBCO's fused aromatic rings increase hydrophobic surface area. A single DBCO on a soluble protein may be unproblematic, but multiple DBCO groups or a DBCO attached to a hydrophobic dye or drug can push the construct toward aggregation, nonspecific surface binding, or low recovery. Hydrophilic PEG spacers or charged linkers can reduce that burden.

BCN has a smaller, less aromatic core, which can be attractive for sterically crowded sites or biomolecules that are already close to a solubility limit. However, the final reagent may still be hydrophobic if the attached linker or payload dominates its behavior. BCN should therefore be selected because the complete construct fits the system, not because the scaffold is automatically "water soluble."

Solubility testing should include the reagent stock and the final reaction mixture. A reagent that dissolves in DMSO but precipitates upon dilution into buffer can create misleadingly low conversion. Keep cosolvent exposure within the stability limits of the protein, antibody, nucleic acid, or material.

Handle orientation can be more important than the choice between DBCO and BCN. In many SPAAC designs, the small azide is placed on the more sensitive or structurally constrained component.

Installing an azide on a protein, antibody, peptide, or oligonucleotide minimizes added mass and hydrophobicity before ligation. The DBCO- or BCN-bearing partner can then be a dye, drug, affinity tag, polymer, or second biomolecule. This orientation is especially useful when the large target must retain native solubility during storage.

The opposite orientation can still be preferable when the cyclooctyne can be installed selectively and the azide-bearing payload is synthetically simpler or more stable. For antibody–oligonucleotide or protein–polymer constructs, whichever component has better purification leverage may be the better place for the larger click handle.

Spacer length should be matched to the local environment. A short linker minimizes added structure but can bury the strained alkyne against the biomolecule. A moderate hydrophilic spacer can increase accessibility and reduce nonspecific interactions. Excessively long flexible linkers may complicate product heterogeneity or downstream structural interpretation.

Different target classes emphasize different properties of the strained alkyne.

A short head-to-head screen usually gives more useful information than choosing from generic property tables.

Analytical methods should verify both click conversion and the physical consequences of adding the strained-alkyne-derived linkage.

LC–MS is useful for peptides, oligonucleotides, and many proteins because it can confirm the expected mass increase and reveal under-labeled or over-labeled species. Intact antibody mass analysis or subunit analysis can provide labeling distributions when the starting material is heterogeneous.

SEC is particularly valuable when DBCO or the attached payload increases hydrophobicity and promotes aggregation. Reversed-phase HPLC can separate small conjugates but may exaggerate apparent hydrophobic differences that are less important in native aqueous conditions. For oligonucleotides, ion-pair reversed-phase or anion-exchange methods may provide better resolution.

Residual unreacted DBCO or BCN reagent should be removed thoroughly because it can interfere with downstream labeling, cell assays, or a second click step. For chromophoric DBCO derivatives, UV absorbance may help track free reagent, but it should not substitute for product identity measurements.

Use the pattern of failure to decide whether the problem is reactivity, solubility, steric access, or purification.

BOC Sciences can develop SPAAC workflows around the actual target and payload rather than treating DBCO or BCN as interchangeable catalog handles.

These references support the structural, kinetic, and application differences discussed for strained cyclooctynes used in SPAAC.

1. Debets MF, van Berkel SS, Schoffelen S, et al. Aza-dibenzocyclooctynes for fast and efficient enzyme PEGylation via copper-free (3 + 2) cycloaddition. Chem Commun. 2010;46:97–99. doi:10.1039/B917797C.
2. Jewett JC, Sletten EM, Bertozzi CR. Rapid Cu-Free Click Chemistry with Readily Synthesized Biarylazacyclooctynones. J Am Chem Soc. 2010;132:3688–3690. doi:10.1021/ja100014q.
3. Dommerholt J, Schmidt S, Temming R, et al. Readily Accessible Bicyclononynes for Bioorthogonal Labeling and Three-Dimensional Imaging of Living Cells. Angew Chem Int Ed. 2010;49:9422–9425. doi:10.1002/anie.201003761.
4. Dommerholt J, Rutjes FPJT, van Delft FL. Strain-Promoted 1,3-Dipolar Cycloaddition of Cycloalkynes and Organic Azides. Top Curr Chem. 2016;374:16. doi:10.1007/s41061-016-0016-4.
5. Terzic V, Pousse G, Méallet-Renault R, Grellier P, Dubois J. Dibenzocyclooctynes: Effect of Aryl Substitution on Their Reactivity toward Strain-Promoted Alkyne–Azide Cycloaddition. J Org Chem. 2019;84:8542–8551. doi:10.1021/acs.joc.9b00895.